The Canadian Medical Association recommends that physicians be provided with ready access to information regarding drug costs so these may be factored into decisions regarding patient care.
The Canadian Medical Association recommends that physicians be provided with ready access to information regarding drug costs so these may be factored into decisions regarding patient care.
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
CMA Letter to the Senate Committee on Legal and Constitutional Affairs regarding
Bill C-2, An Act to amend the Criminal Code and to make consequential amendments to other Acts
The Canadian Medical Association supports the position that:
1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and
2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
The Canadian Medical Association supports the position that:
1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and
2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
The Canadian Medical Association urges the federal minister of health to prohibit claims of the therapeutic value of natural health products for the treatment of diseases listed in Schedule A of the Food and Drug Act when the supportive evidence does not meet the evidentiary standard required of medications regulated by the Health Products and Food Branch of Health Canada.
The Canadian Medical Association urges the federal minister of health to prohibit claims of the therapeutic value of natural health products for the treatment of diseases listed in Schedule A of the Food and Drug Act when the supportive evidence does not meet the evidentiary standard required of medications regulated by the Health Products and Food Branch of Health Canada.
The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
The Right Drugs, at the Right Times, for the Right Prices: Toward a Prescription Drug Policy for Canada : CMA Presentation to House of Commons Standing Committee on Health
